• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries.

作者信息

Rego Eduardo Magalhães

机构信息

Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - USP, Ribeirão Preto, SP, Brazil ; International Consortium on Acute Promyelocytic Leukemia.

出版信息

Rev Bras Hematol Hemoter. 2013;35(1):1-2. doi: 10.5581/1516-8484.20130001.

DOI:10.5581/1516-8484.20130001
PMID:23580871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3621622/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df6/3621622/5e4e9f447336/rbhh-35-001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df6/3621622/5e4e9f447336/rbhh-35-001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df6/3621622/5e4e9f447336/rbhh-35-001-g01.jpg

相似文献

1
The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries.国际急性早幼粒细胞白血病联盟的成果：作为一种改善发展中国家血液系统恶性肿瘤治疗结果的策略，网络建设的“概念验证”
Rev Bras Hematol Hemoter. 2013;35(1):1-2. doi: 10.5581/1516-8484.20130001.
2
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.通过建立网络改善发展中国家的急性早幼粒细胞白血病（APL）预后：国际 APL 联盟的研究结果。
Blood. 2013 Mar 14;121(11):1935-43. doi: 10.1182/blood-2012-08-449918. Epub 2013 Jan 14.
3
Survival and treatment response in adults with acute promyelocytic leukemia treated with a modified International Consortium on Acute Promyelocytic Leukemia protocol.采用改良的国际急性早幼粒细胞白血病联合会方案治疗的成人急性早幼粒细胞白血病患者的生存情况及治疗反应
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):285-290. doi: 10.1016/j.bjhh.2016.08.002. Epub 2016 Sep 21.
4
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).医学教育与交流网络对发展中国家白血病治疗结果的影响。急性早幼粒细胞白血病国际联盟（IC-APL）的经验。
Hematology. 2012 Apr;17 Suppl 1:S36-8. doi: 10.1179/102453312X13336169155376.
5
Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.拉丁美洲急性早幼粒细胞白血病的治疗：国际白血病联盟经验教训
Br J Haematol. 2017 Jun;177(6):979-983. doi: 10.1111/bjh.14589. Epub 2017 May 3.
6
Acute promyelocytic leukemia: progress far and wide.急性早幼粒细胞白血病：远瞩高瞻，成果斐然。
Blood. 2013 Mar 14;121(11):1925-6. doi: 10.1182/blood-2012-12-470757.
7
Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia.国际急性早幼粒细胞白血病联盟提出的治疗新诊断急性早幼粒细胞白血病患者方案的成本效益。
Hematol Transfus Cell Ther. 2021 Oct-Dec;43(4):476-481. doi: 10.1016/j.htct.2020.08.013. Epub 2020 Oct 11.
8
Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients.一名中间型地中海贫血女性患急性早幼粒细胞白血病：病例报告及β地中海贫血患者血液系统恶性肿瘤文献综述
Hematol Rep. 2022 Oct 21;14(4):310-321. doi: 10.3390/hematolrep14040045.
9
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.KMT2E 转录本水平对全反式维甲酸和蒽环类化疗治疗的急性早幼粒细胞白血病患者预后的影响：国际急性早幼粒细胞白血病联盟研究。
Br J Haematol. 2014 Aug;166(4):540-9. doi: 10.1111/bjh.12921. Epub 2014 May 3.
10
Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.人类血液系统恶性肿瘤来源细胞上共刺激分子的表达模式
J Exp Clin Cancer Res. 1998 Sep;17(3):251-8.

引用本文的文献

1
Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them.现实世界中的急性早幼粒细胞白血病：理解结局差异以及我们如何改善这些差异。
Cancers (Basel). 2024 Dec 6;16(23):4092. doi: 10.3390/cancers16234092.
2
All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations.全反式维甲酸增强了quizartinib在伴有FLT3-ITD突变的急性髓系白血病中诱导的细胞死亡。
Ann Hematol. 2024 Dec;103(12):5405-5416. doi: 10.1007/s00277-024-06089-w. Epub 2024 Dec 11.
3
Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia.

本文引用的文献

1
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.通过建立网络改善发展中国家的急性早幼粒细胞白血病（APL）预后：国际 APL 联盟的研究结果。
Blood. 2013 Mar 14;121(11):1935-43. doi: 10.1182/blood-2012-08-449918. Epub 2013 Jan 14.
2
ED in APL: tip of the iceberg?急性早幼粒细胞白血病中的急诊情况：冰山一角？
Blood. 2011 Aug 4;118(5):1188-9. doi: 10.1182/blood-2011-06-361238.
3
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.
成人急性早幼粒细胞白血病十二年随访及预后情况
Hematol Transfus Cell Ther. 2021 Jan-Mar;43(1):21-27. doi: 10.1016/j.htct.2019.12.001. Epub 2020 Jan 23.
4
The Guidelines Project: Brazilian guidelines for acute promyelocytic leukemia.指南项目：巴西急性早幼粒细胞白血病指南
Rev Bras Hematol Hemoter. 2014;36(1):1-2. doi: 10.5581/1516-8484.20140001.
尽管采用全反式维甲酸治疗，但急性早幼粒细胞白血病的早期死亡率仍然很高。
Blood. 2011 Aug 4;118(5):1248-54. doi: 10.1182/blood-2011-04-346437. Epub 2011 Jun 8.
4
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.急性早幼粒细胞白血病的持续高早期死亡率：来自瑞典成人急性白血病登记处的一项基于人群的报告。
Leukemia. 2011 Jul;25(7):1128-34. doi: 10.1038/leu.2011.78. Epub 2011 Apr 19.
5
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.AIDA 0493 方案治疗初发急性早幼粒细胞白血病：极长期结果和维持治疗的作用。
Blood. 2011 May 5;117(18):4716-25. doi: 10.1182/blood-2010-08-302950. Epub 2011 Mar 8.
6
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.三氧化二砷可改善急性早幼粒细胞白血病成人患者的无事件生存和总生存：北美白血病协作组研究 C9710。
Blood. 2010 Nov 11;116(19):3751-7. doi: 10.1182/blood-2010-02-269621. Epub 2010 Aug 12.
7
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.基于全反式维甲酸和蒽环类药物联合阿糖胞苷巩固治疗高危患者的急性早幼粒细胞白血病的风险适应性治疗：治疗结果的进一步改善。
Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14.
8
Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.134例接受全反式维甲酸和蒽环类药物治疗的巴西急性早幼粒细胞白血病患者的临床特征与预后
Haematologica. 2007 Oct;92(10):1431-2. doi: 10.3324/haematol.10874.
9
Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.小鼠模型中急性早幼粒细胞白血病的分子遗传学分析。
Semin Hematol. 2001 Jan;38(1):54-70. doi: 10.1016/s0037-1963(01)90006-x.
10
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).应用单克隆抗体PG-M3（抗早幼粒细胞白血病蛋白）对急性早幼粒细胞白血病（M3型）进行免疫细胞化学诊断。
Blood. 1997 Nov 15;90(10):4046-53.